From classroom to clinic: McCormick students’ invention aims to improve tuberculosis testing efficiency in developing countries

Biomedical engineering students develop promising technology to help test for tuberculosis in developing countries.

Monkeypox Rapid PCR Test in Development

CIGHT researchers adapt COVID-19 rapid PCR testing platform to detect monkeypox.

Rapid PCR Test Receives FDA Emergency Use Authorization

CIGHT developed COVID-19 PCR test receives clearance to continue in fight against COVID-19.

Northwestern Spinoff Receives $21.3M from NIH to Manufacture COVID-19 Test

Northwestern and Minute Molecular Diagnostics are developing and commercializing a COVID PCR testing device that can produce results in 15 minutes.

A Race Against Time: Developing Diagnostics For The Developing World

Northwestern’s Center for Innovation in Global Health Technologies tailors medical diagnostics to meet life-or-death challenges in the developing world.

From Here to Timbuktu

Physician Robert ­Murphy ­facilitates research and training programs in the ­developing world as ­director of Northwestern’s Center for Global Health.

NU Faculty Member Appointed Nigeria's Minister of Health

Isaac Adewole, MBBS, adjunct professor of Medicine and a native of Nigeria, has been sworn in as the African country’s minister of health.

Designed for Life

A decade in the making, low-cost infant-HIV test nears clinical use.

Developing Medical Devices for the Developing World

Sixteen Northwestern students traveled to Cape Town this spring as part of McCormick’s Global Health Technologies study abroad program.

Optimizing Tuberculosis Case Detection through a Novel Diagnostic Device Placement Model: The Case of Uganda

Xpert MTB/RIF (Xpert) is being widely adopted in high TB burden countries. Analysis is needed to guide the placement of devices within health systems to optimize the tuberculosis (TB) case detection rate (CDR).

A simple and rapid DNA extraction method from whole blood for highly sensitive detection and quantitation of HIV-1 proviral DNA by real-time PCR

Friday, January 23, 2015

Early diagnosis and access to treatment for infants with human immunodeficiency virus-1 (HIV-1) is critical to reduce infant mortality. In this report, significant improvements in the DNA extraction and amplification methods are detailed that allow sensitive quantitation of as little as 10 copies of HIV-1 proviral DNA and detection of three copies extracted from 100% of whole blood.